Thrombolysis in Patients with Transient Neurologic Deficits
Neurol 57:2125-2128, Lyden,P.,et al, 2001
Thrombolytic Therapy in Acute Ischemic Stroke Patients With Cardiac Thrombus
Neurol 57:2122-2125, Derex,L.,et al, 2001
Treatment of Acute Basilar Artery Thrombosis With a Combination of Systemic Alteplase and Tirofiban, a Nonpeptide Platelet Glycoprotein IIb/IIIa Inhibitor: Report of Four Cases
Radiology 221:795-801, Junghans,U.,et al, 2001
Ischemic Stroke and Active Migraine
Neurol 57:1805-1811, Milhaud,D.,et al, 2001
MRI Hyperintensities of the Temporal Lobe and External Capsule in Patients with CADASIL
Neurol 56:628-634, O'Sullivan,M.,et al, 2001
Acute Obstructive Hydrocephalus Heralding Neurocysticercosis
Conn Med 65:451-454, Finelli,P.F., 2001
Cerebral Venous Thrombosis and Isolated Intracranial Hypertension Without Papilledema in CDH
Neurol 57:31-36, Quattrone,A.,et al, 2001
Stroke in a Healthy 46-Year-Old Man
JAMA 285:2757-2762, Wityk,R.J., 2001
Clinical Presentation of Left Atrial Cardiac Myxoma
Medicine 80:159-172, Pinede,L.,et al, 2001
Safety of Intra-Arterial Thrombolysis in the Postoperative Period
Stroke 32:1365-1369, Chalela,J.A.,et al, 2001
Benefits of Perfusion MR Imaging Relative to Diffusion MR Imaging in the Diagnosis and Treatment of Hyperacute Stroke
AJNR 22:915-921,806, Sunshine,J.L.,et al, 2001
Stroke Prevention and Treatment in Sickle Cell Disease
Arch Neurol 58:565-568, Adams,R.J., 2001
Why Are Stroke Patients Excluded from TPA Therapy?
Neurol 56:1015-1020, Barber,P.A.,et al, 2001
Cerebral Sinus Thrombosis with Tamoxifen
Neurol 56:1113-1114, Finelli,P.F. & Schauer,P.K., 2001
Intraarterial Thrombolysis: Ready for Prime Time?
AJNR 22:55-58, Executive Committee of the ASITN, 2001
Improved Cerebrovascular Patency Following Therapy in Patients with Sickle Cell Disease: Initial Results in 4 Patients Who Received HLA-Identical Hematopoietic Stem Cell Allografts
Ann Neurol 49:222-229, Steen,R.G.,et al, 2001
Diffusion-weighted Imaging Patterns of Brain Damage Associated with Cerebral Venous Thrombosis
AJNR 22:261-268, Ducreux,D.,et al, 2001
Combined Intraarterial/Intravenous Thrombolysis for Acute Ischemic Stroke
AJNR 22:352-358, Keris,V.,et al, 2001
Deterioration Following Improvement with tPA Therapy: Carotid Thrombosis and Reocclusion
Neurol 56:568-570, Burgin,W.S. &Alexandrov,A.V., 2001
Use of Specialized Coagulation Testing in the Evaluation of Patients with Acute Ischemic Stroke
Neurol 56:624-627, Bushnell,C.,et al, 2001
Sustained Bilateral Hemodynamic Benefit of Contralateral Carotid Endarterectomy in Patients with Symptomatic Internal Carotid Artery Occlusion
Stroke 32:728-734, Rutgers,D.R.,et al, 2001
Stroke Magnetic Resonance Imaging Within 6 Hours After Onset of Hyperacute Cerebral Ischemia
Ann Neurol 49:460-469, Schellinger,P.D.,et al, 2001
Cerebrovascular Manifestations in 321 Cases of Hereditary Hemorrhagic Telangiectasia
Stroke 32:877-882, Maher,C.O.,et al, 2001
Intravenous tPA for Ischemic Stroke Team Performance Over Time, Safety, and Efficacy in a Single-Center, 2-Year Experience
Stroke 32:1074-1078, Koennecke,H.,et al, 2001
Immediate Surgery for Moyomoya Syndrome?
Arch Neurol 58:130-131,132, Roach,E.S., 2001
Surgery for Moyamoya Syndrome?
Arch Neurol 58:128-129,132, Scott,R.M., 2001
Cerebral Venous Thrombosis Presenting as Acute Visual Loss
Br J Ophthalmol 85:1139, Ko,Y.-C.,et al, 2001
Bicuspid Aortic Valve - A Silent Danger: Analysis of 50 Cases of Infective Endocarditis
Clin Inf Dis 30:336-341, Lamas, C.C. & Eykyn, S.J., 2000
Subarachnoid Haemorrhage Treated with Anticoagulants
Lancet 356:1818, Ciccone,A.,et al, 2000
Stroke and Pregnancy
Stroke 31:2948-2951, Jaigobin,C. & Silver,F.L., 2000
Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Stroke 31:2920-2924, Chapman,K.M.,et al, 2000
Corpus Callosum Infarcts with Atypical Clinical and Radiologic Presentations
AJNR 21:1876-1880, Kasow,D.L.,et al, 2000
Combined Intravenous and Intra-Arterial Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke
Stroke 31:2552-2557, Ernst,R.,et al, 2000
Homocysteine and Neurologic Disease
Arch Neurol 57:1422-1428, Diaz-Arrastia,R., 2000
Interatrial Septal Abnormalities and Stroke
Neurol 55:1172-1179, Overell,J.R.,et al, 2000
Pulmonary Arteriovenous Malformations
Neurol 55:959-964, Moussouttas,M.,et al, 2000
Cerebral Venous Thrombosis: Anticoagulants or Thrombolyic Therapy?
JNNP 69:427-430, Benamer,H.T.S. & Bone,I., 2000
Adverse Cardiovascular and Central Nervous System Events Associated with Dietary Supplements Containing Ephedra Alkaloids
NEJM 343:1833-1838,1886, Haller,C.A. & Benowitz,N.L., 2000
Phenylpropanolamine and the Risk of Hemorrhagic Stroke
NEJM 343:1826-1832,1886, Kernan,W.N.,et al, 2000
Ischemic Stroke in Young Women: Risk of Recurrence During Subsequent Pregnancies
Neurol 55:269-274, Lamy,C. et al, 2000
Stroke Mimicry: Four Cases Eligible for Tissue Plasminogen Activator
The Neurologist 6:220-223, Kirshner, H.S., 2000
Ischemic Stroke Risk With oral Contraceptives
JAMA 284:72-78, Gillum,L.A. et al, 2000
Facial Palsy in Cerebral Venous Thrombosis
Stroke 31:1766-1769, Straub,J. et al, 2000
Serum Lipids in Young Patients with Ischaemic Stroke: A Case-control Study
JNNP 69:29-33, Albucher,J.F. et al, 2000
An Uncommon Cause of Recurrent Strokes
Stroke 31:2002-2003, Naegeli,B. et al, 2000
Treatment of Acute Ischemic Stroke
NEJM 343:710-722, Brott, T. & Bogousslavsky, J., 2000
Selective Infusion of Urokinase and Thrombectomy in the Treatment of Acute Cerebral Sinus Thrombosis
AJNR 21:143-145, Novak,Z.,et al, 2000
Superior Sagittal Sinus Thrombosis Due to Lithium:Local Urokinase Thrombolysis Treatment
Neurol 54:532-533, Wasay,M.,et al, 2000
Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Patients Aged 80 Years and Older, The tPa Stroke Survey Experience
Stroke 31:370-375, Tanne,D.,et al, 2000
Treating Acute Stroke Patients with Intravenous tPA, The OSF Stroke Network Experience
Stroke 31:77-81, Wang,D.Z.,et al, 2000